European Journal of Inorganic Chemistry · 2009 · 39 citations · 22 references
MedicineChemistryOncologyCancer PharmacologyChemotherapyDrug DiscoveryAntineoplastic Drug InteractionsCytotoxic ChemotherapyLanthanide ChemistryAnticancer Drug InteractionsCapillary ElectrophoresisDiffraction AnalysisLanthanide ChelationLanthanide ComplexesLanthanide Coordination ChemistryLanthanide HalidesX-ray Diffraction Analysis
Abstract The lanthanide complex tris(1,10‐phenanthroline)tris(thiocyanato‐κ N )lanthanum(III) [La(phen) 3 (NCS) 3 ] (KP772) is a promising anticancer drug candidate, capable of overcoming resistance of tumors to established chemotherapeutics. The compound was characterized by elemental analysis, IR, 1 H NMR spectroscopy, TG/DTA measurements, mass spectrometry and X‐ray diffraction analysis. The results indicate that KP772 is a neutral, nine‐coordinate complex. In addition the behavior in water, important for the application as a chemotherapeutic drug, and the binding to biomolecules was investigated by capillary electrophoresis and ICP‐MS.(© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)
22
Junnosuke Fujita, Kazuo Nakamoto, Masahisa Kobayashi · Journal of the American Chemical Society · 1956 · 132 citations